Genespire Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $51.7M

  • Investors
  • 5

Genespire General Information

Description

Developer of transformative gene therapies designed to treat patients affected by severe genetic diseases. The company's therapies combine integration-defective lentiviral vectors with gene editing for high-efficacy and versatile targeted insertion of therapeutic genes in blood cells, enabling patients to have an arsenal of therapeutic alternatives adapted to each specific disease.

Contact Information

Website
www.genespire.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Visconti di Modrone, 18
  • 20122 Milan
  • Italy
+39 02
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Via Visconti di Modrone, 18
  • 20122 Milan
  • Italy
+39 02

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genespire Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 25-Sep-2024 $51.7M Completed Generating Revenue
1. Early Stage VC (Series A) 20-Apr-2020 Completed Generating Revenue
To view Genespire’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Genespire Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of transformative gene therapies designed to treat patients affected by severe genetic diseases. The company's
Drug Discovery
Milan, Italy
10 As of 2024

Ecublens, Switzerland
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genespire Competitors (44)

One of Genespire’s 44 competitors is Anokion, a Venture Capital-Backed company based in Ecublens, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Anokion Venture Capital-Backed Ecublens, Switzerland
Senti Bio Formerly VC-backed South San Francisco, CA
Fauna Bio Venture Capital-Backed Emeryville, CA
NeRRe Therapeutics Venture Capital-Backed Stevenage, United Kingdom
ENYO Pharma Venture Capital-Backed Lyon, France
You’re viewing 5 of 44 competitors. Get the full list »

Genespire Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 5

    Pending

  • Expiring in next 12 mo

Genespire Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202315668-D0 Gene therapy Pending 12-Oct-2023
GB-202214990-D0 Lentiviral vector Inactive 11-Oct-2022
GB-202205606-D0 Lentiviral vector Inactive 14-Apr-2022
GB-202205615-D0 Lentiviral vector Inactive 14-Apr-2022
GB-202205608-D0 Lentiviral vector Inactive 14-Apr-2022
To view Genespire’s complete patent history, request access »

Genespire Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genespire Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDP Venture Capital Venture Capital Minority
Indaco Venture Partners Venture Capital Minority
Large Ventures Venture Capital Minority
XGEN Venture Impact Investing Minority
Sofinnova Partners Venture Capital Minority
To view Genespire’s complete investors history, request access »

Ready to get started?

Request a free trial

Genespire FAQs

  • When was Genespire founded?

    Genespire was founded in 2020.

  • Where is Genespire headquartered?

    Genespire is headquartered in Milan, Italy.

  • What is the size of Genespire?

    Genespire has 10 total employees.

  • What industry is Genespire in?

    Genespire’s primary industry is Drug Discovery.

  • Is Genespire a private or public company?

    Genespire is a Private company.

  • What is Genespire’s current revenue?

    The current revenue for Genespire is .

  • How much funding has Genespire raised over time?

    Genespire has raised $69.2M.

  • Who are Genespire’s investors?

    CDP Venture Capital, Indaco Venture Partners, Large Ventures, XGEN Venture, and Sofinnova Partners have invested in Genespire.

  • Who are Genespire’s competitors?

    Anokion, Senti Bio, Fauna Bio, NeRRe Therapeutics, and ENYO Pharma are some of the 44 competitors of Genespire.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »